Product Information
SOLU-CORTEF 100 MG ACT-O-VIAL is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $24.6832 per EA under NDC 00009001104. Its NADAC has been published 124 times since May 22, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
100 mg/2mL
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009001104
Classification
Brand
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
7/1/2026
Active Ingredients
HYDROCORTISONE SODIUM SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA009866FDA Approved
Before 1982
TE Code
AP
On Market Since
4/27/1955
Pharmacological Classes
Price Statistics
The NADAC for SOLU-CORTEF 100 MG ACT-O-VIAL has been published 124 times since May 22, 2024, and over the history we have for it it has risen 25.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $24.6832 per EA |
|---|---|
| All-time high | $24.6832 (Sep 30, 2026) |
| All-time low | $19.6868 (Jun 19, 2024) |
| 52-week high | $24.6832 |
| 52-week low | $22.5507 |
| Median price | $23.0716 |
| Average price | $22.5025 |
| Largest weekly change | +5.0% (Jan 8, 2025) |
| Weeks tracked | 124 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pharmacia & Upjohn Company LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
hydrocortisone sodium succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SOLU-CORTEF 100 MG ACT-O-VIAL?
The current National Average Drug Acquisition Cost (NADAC) for SOLU-CORTEF 100 MG ACT-O-VIAL, manufactured by Pharmacia & Upjohn Company LLC, is $24.6832 per EA (NDC 00009001104), effective Sep 30, 2026.
How has the price of SOLU-CORTEF 100 MG ACT-O-VIAL changed over time?
Over the history we have for it, the NADAC for SOLU-CORTEF 100 MG ACT-O-VIAL has risen 25.3%. It has been tracked across 124 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for SOLU-CORTEF 100 MG ACT-O-VIAL?
Since May 22, 2024, the NADAC for SOLU-CORTEF 100 MG ACT-O-VIAL has ranged from a low of $19.6868 (Jun 19, 2024) to a high of $24.6832 (Sep 30, 2026), with a median of $23.0716 per EA.
Are there cheaper alternatives to SOLU-CORTEF 100 MG ACT-O-VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SOLU-CORTEF 100 MG ACT-O-VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures SOLU-CORTEF 100 MG ACT-O-VIAL?
SOLU-CORTEF 100 MG ACT-O-VIAL (NDC 00009001104) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.